Pathfinder Cell Therapy, Inc.
PFND · OTC
12/31/2014 | 12/31/2013 | 12/31/2012 | 12/31/2011 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,394 | -$1,705 | -$2,156 | -$11,270 |
| Dep. & Amort. | $3 | $11 | $20 | $19 |
| Deferred Tax | -$2 | -$5 | $0 | $7,668 |
| Stock-Based Comp. | $2 | $5 | $12 | $527 |
| Change in WC | $426 | $174 | $83 | $163 |
| Other Non-Cash | $2 | -$81 | $17 | $563 |
| Operating Cash Flow | -$963 | -$1,601 | -$2,024 | -$2,330 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $14 |
| Inv. Purchases | $0 | $0 | $0 | -$849 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | -$835 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $1,837 | $2,063 |
| Stock Issued | $0 | $0 | $0 | $1,283 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $945 | $1,636 | $0 | $0 |
| Financing Cash Flow | $945 | $1,636 | $1,837 | $3,346 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$18 | $35 | -$187 | $181 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $44 | $9 | $196 | $15 |
| End Cash | $26 | $44 | $9 | $196 |
| Free Cash Flow | -$963 | -$1,601 | -$2,024 | -$2,330 |